Solving doubts about L-ornithine L-aspartate for overt hepatic encephalopathy: Whom and how to treat

被引：8

作者：

Amodio, Piero ^{[1
]}

Ampuero, Javier ^{[2
,3
]}

机构：

[1] Univ Padua, Dept Med DIMED, Via Giustiniani 2, I-35128 Padua, Italy

[2] Virgen del Rocio Univ Hosp, Unit Clin Management Digest Dis, Seville, Spain

[3] Virgen del Rocio Univ Hosp, CIBERehd, Seville, Spain

来源：

HEPATOLOGY | 2018年 / 67卷 / 02期

关键词：

CIRRHOSIS; LACTULOSE; RIFAXIMIN; TRIAL;

D O I：

10.1002/hep.29530

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页码：476 / 478

页数：3

相关论文

共 10 条

[1]

Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients [J].

Amodio, P ;

Del Piccolo, F ;

Pettenò, E ;

Mapelli, D ;

Angeli, P ;

Iemmolo, R ;

Muraca, M ;

Musto, C ;

Gerunda, G ;

Rizzo, C ;

Merkel, C ;

Gatta, A .

JOURNAL OF HEPATOLOGY, 2001, 35 (01) :37-45

[2]

l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials [J].

Bai, Ming ;

Yang, Zhiping ;

Qi, Xingshun ;

Fan, Daiming ;

Han, Guohong .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (05) :783-792

[3]

Rifaximin Treatment in Hepatic Encephalopathy [J].

Bass, Nathan M. ;

Mullen, Kevin D. ;

Sanyal, Arun ;

Poordad, Fred ;

Neff, Guy ;

Leevy, Carroll B. ;

Sigal, Samuel ;

Sheikh, Muhammad Y. ;

Beavers, Kimberly ;

Frederick, Todd ;

Teperman, Lewis ;

Hillebrand, Donald ;

Huang, Shirley ;

Merchant, Kunal ;

Shaw, Audrey ;

Bortey, Enoch ;

Forbes, William P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (12) :1071-1081

[4]

Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report [J].

Di Pascoli, Marco ;

Ceranto, Elena ;

De Nardi, Paolo ;

Donato, Daniele ;

Gatta, Angelo ;

Angeli, Paolo ;

Pontisso, Patrizia .

DIGESTIVE DISEASES, 2017, 35 (05) :433-438

[5]

Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence? [J].

Gluud, Lise Lotte ;

Dam, Gitte ;

Borre, Mette ;

Les, Inigo ;

Cordoba, Juan ;

Marchesini, Giulio ;

Aagaard, Niels Kristian ;

Vilstrup, Hendrik .

METABOLIC BRAIN DISEASE, 2013, 28 (02) :221-225

[6]

Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial [J].

Maharshi, Sudhir ;

Sharma, Barjesh Chander ;

Sachdeva, Sanjeev ;

Srivastava, Siddharth ;

Sharma, Praveen .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (03) :454-+

[7]

Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo [J].

Sharma, Barjesh Chander ;

Sharma, Praveen ;

Agrawal, Amit ;

Sarin, Shiv Kumar .

GASTROENTEROLOGY, 2009, 137 (03) :885-891

[8]

Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis [J].

Shawcross, DL ;

Davies, NA ;

Williams, R ;

Jalan, R .

JOURNAL OF HEPATOLOGY, 2004, 40 (02) :247-254

[9]

L-ornithine L-aspartate in bouts of overt hepatic encephalopathy [J].

Sidhu, Sandeep Singh ;

Sharma, Barjesh Chander ;

Goyal, Omesh ;

Kishore, Harsh ;

Kaur, Navpreet .

HEPATOLOGY, 2018, 67 (02) :700-710

[10]

Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver [J].

Vilstrup, Hendrik ;

Amodio, Piero ;

Bajaj, Jasmohan ;

Cordoba, Juan ;

Ferenci, Peter ;

Mullen, Kevin D. ;

Weissenborn, Karin ;

Wong, Philip .

HEPATOLOGY, 2014, 60 (02) :715-735